Literature DB >> 15763233

Long-term management of alcoholic liver disease.

Jamilé Wakim-Fleming1, Kevin D Mullen.   

Abstract

Despite the epidemics of viral hepatitis C and nonalcoholic fatty liver disease, alcohol remains one of the major causes of liver disease. Commonly, hepatitis C and other liver diseases are found in association with alcohol consumption. This association in many instances is noted to accelerate the progression of liver disease. In many respects, the long-term management of alcoholic liver disease is not dissimilar from the long-term management of patients with cirrhosis from other etiologies. One major element is the abstinence of alcohol use. The ability to maintain sobriety has a major impact on the outcome of patients with alcoholic cirrhosis because maintaining abstinence can lead to significant regression of fibrosis and possibly early cirrhosis. Similarities in managing patients with cirrhosis due to alcohol or cirrhosis from other causes include vaccination to prevent superimposed viral hepatitis and screening for esophageal varices and hepatocellular carcinoma with subsequent appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763233     DOI: 10.1016/j.cld.2004.10.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  9 in total

1.  Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.

Authors:  Irina A Kirpich; Craig J McClain; Vatsalya Vatsalya; Melanie Schwandt; Monte Phillips; Keith Cameron Falkner; Lucy Zhang; Catey Harwell; David T George; John C Umhau
Journal:  Alcohol Clin Exp Res       Date:  2017-03-02       Impact factor: 3.455

2.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

Authors:  Irina A Kirpich; Joseph Petrosino; Nadim Ajami; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Shirish S Barve; Xinmin Yin; Xiaoli Wei; Xiang Zhang; Craig J McClain
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

3.  Dietary Linoleic Acid and Its Oxidized Metabolites Exacerbate Liver Injury Caused by Ethanol via Induction of Hepatic Proinflammatory Response in Mice.

Authors:  Dennis R Warner; Huilin Liu; Matthew E Miller; Christopher E Ramsden; Bin Gao; Ariel E Feldstein; Susanne Schuster; Craig J McClain; Irina A Kirpich
Journal:  Am J Pathol       Date:  2017-10       Impact factor: 4.307

4.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

5.  Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study.

Authors:  Zhe Shen; You-Ming Li; Chao-Hui Yu; Yi Shen; Lei Xu; Cheng-Fu Xu; Jin-Jin Chen; Hua Ye; Gen-Yun Xu
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

6.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

Authors:  Irina A Kirpich; Natalia V Solovieva; Svetlana N Leikhter; Natalia A Shidakova; Oxsana V Lebedeva; Pavel I Sidorov; Tatjana A Bazhukova; Andrej G Soloviev; Shirish S Barve; Craig J McClain; Matt Cave
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

Review 7.  Alcoholic Liver Disease: Update on the Role of Dietary Fat.

Authors:  Irina A Kirpich; Matthew E Miller; Matthew C Cave; Swati Joshi-Barve; Craig J McClain
Journal:  Biomolecules       Date:  2016-01-06

8.  Port-site metastasis as a primary complication following retroperitoneal laparoscopic radical resection of renal pelvis carcinoma or nephron-sparing surgery: A report of three cases and review of the literature.

Authors:  Ning Wang; Kai Wang; Dachuan Zhong; Xia Liu; J I Sun; Lianxiang Lin; Linna Ge; B O Yang
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

9.  Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis.

Authors:  Zhiyun Cheng; Yinghui Lv; Suqiu Pang; Ruyu Bai; Mingxi Wang; Shuyu Lin; Tianwen Xu; Duncan Spalding; Nagy Habib; Ruian Xu
Journal:  Acta Pharm Sin B       Date:  2015-04-07       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.